Grant: Collaborative Health Research Projects
University of Ottawa
$98,628.00
Anti-microbial scaffold materials for cutaneous wound healing
FY 2013-14
Summary
This proposed research is focused on the development of new functional biomaterials for the repair of chronic degradation and infection of skin. Loss of nerves and sensitivity occur in the skin of extremities in chronic type II diabetes, often resulting in epithelial erosion and ulceration. In addition to the loss of sensitivity, the chronic ulceration renders the skin prone to bacterial infection that can lead to gangrene and amputations. In addition, although skin and skin substitutes have been around for a long time for use in burn patients, there are still issues with scarring, especially for deeper skin wounds that involve the dermis and sub-cutaneous fat tissue. Successful strategies for such reconstruction of skin depend crucially on the availability of scaffold materials that (1) recapitulate the native extracellular matrix (ECM) environment (a largely collagenous matrix withproteoglycans and cell interactive proteins such as laminin and fibronectin) and (2) incorporate anti-microbial or anti-septic constituents for preventing or managing infections. The assembled team has complimentary expertise in the development of hydrogel scaffold materials (based on natural and synthetic macromolecules) for regenerative medicine, engineered peptides with anti-microbial activity, microbiology of biofilms, and particle-based nanomaterials for drug delivery and diagnostic applications. In this project, we will apply our expertise to create novel nanocomposite biomaterials for skin regeneration based on engineered collagen scaffolds that incorporate modular designer proteins with cell binding, antibacterial activity, and signally abilities and metallic nanoparticles with innate and patient-safe antimicrobial activity.
Program
Collaborative Health Research Projects
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
414290-2012
Name nom
Harden, James
Department département
Physics
Organization id
28
Institution établissement
University of Ottawa
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2012
Award amount
98628
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1902
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical materials
Research subject fr
Matériaux biomédicaux
Partie
2 & 3
Nb partie
3
Application title
Anti-microbial scaffold materials for cutaneous wound healing
Keyword
NSERC
Application summary
This proposed research is focused on the development of new functional biomaterials for the repair of chronic degradation and infection of skin. Loss of nerves and sensitivity occur in the skin of extremities in chronic type II diabetes, often resulting in epithelial erosion and ulceration. In addition to the loss of sensitivity, the chronic ulceration renders the skin prone to bacterial infection that can lead to gangrene and amputations. In addition, although skin and skin substitutes have been around for a long time for use in burn patients, there are still issues with scarring, especially for deeper skin wounds that involve the dermis and sub-cutaneous fat tissue. Successful strategies for such reconstruction of skin depend crucially on the availability of scaffold materials that (1) recapitulate the native extracellular matrix (ECM) environment (a largely collagenous matrix withproteoglycans and cell interactive proteins such as laminin and fibronectin) and (2) incorporate anti-microbial or anti-septic constituents for preventing or managing infections. The assembled team has complimentary expertise in the development of hydrogel scaffold materials (based on natural and synthetic macromolecules) for regenerative medicine, engineered peptides with anti-microbial activity, microbiology of biofilms, and particle-based nanomaterials for drug delivery and diagnostic applications. In this project, we will apply our expertise to create novel nanocomposite biomaterials for skin regeneration based on engineered collagen scaffolds that incorporate modular designer proteins with cell binding, antibacterial activity, and signally abilities and metallic nanoparticles with innate and patient-safe antimicrobial activity.